Add to ORKGBackground Adult brainstem gliomas are rare primary brain tumors (<2% of gliomas). The goal of this study was to analyze clinical, prognostic and therapeutic factors in a large series of histologically proven brainstem gliomas. Methods Between 1997 and 2007, 104 patients with a histologically proven brainstem glioma were retrospectively analyzed. Data about clinical course of disease, neuropathological findings and therapeutic approaches were analyzed. Results The median age at diagnosis was 41 years (range 18-89 years), median KPS before any operative procedure was 80 (range 20-100) and median survival for the whole cohort was 18.8 months. Histopathological examinations revealed 16 grade I, 31 grade II, 42 grade III and 14 grade IV gl...
BACKGROUND: Brainstem tumors represent 10% of central nervous system tumors, accounting for 30% of p...
Malignant glioblastoma multiforme, or glioma, is one of the most frequent central nervous system tum...
Objective: To evaluate characteristics and treatment responses of patients with high grade gliomas (...
Background and objectives: Brainstem gliomas are tumors of the central nervous system which have var...
Because of low incidence, mixed study populations and paucity of clinical and histological data, the...
Because of low incidence, mixed study populations and paucity of clinical and histological data, the...
Purpose: The aim of this study was to assess the outcome in patients with cerebellar glioblastoma (G...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Diffuse type brainstem gliomas, one of the most malignant brain tumors, have an extremely poor progn...
In the present study, we have determined the prognostic value and observed the clinicopathological f...
Background: Glioblastoma multiforme (GBM) is the most aggressive brain tumor that occurs in adults. ...
Prognostic factor analyses have proven useful in predicting outcome in patients with newly diagnosed...
BACKGROUND: Brainstem tumors represent 10% of central nervous system tumors, accounting for 30% of ...
BACKGROUND: Brainstem tumors represent 10% of central nervous system tumors, accounting for 30% of p...
Malignant glioblastoma multiforme, or glioma, is one of the most frequent central nervous system tum...
Objective: To evaluate characteristics and treatment responses of patients with high grade gliomas (...
Background and objectives: Brainstem gliomas are tumors of the central nervous system which have var...
Because of low incidence, mixed study populations and paucity of clinical and histological data, the...
Because of low incidence, mixed study populations and paucity of clinical and histological data, the...
Purpose: The aim of this study was to assess the outcome in patients with cerebellar glioblastoma (G...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Purpose: Analysis of the results of radiotherapy in a Large group of cerebral gliomas with identific...
Diffuse type brainstem gliomas, one of the most malignant brain tumors, have an extremely poor progn...
In the present study, we have determined the prognostic value and observed the clinicopathological f...
Background: Glioblastoma multiforme (GBM) is the most aggressive brain tumor that occurs in adults. ...
Prognostic factor analyses have proven useful in predicting outcome in patients with newly diagnosed...
BACKGROUND: Brainstem tumors represent 10% of central nervous system tumors, accounting for 30% of ...
BACKGROUND: Brainstem tumors represent 10% of central nervous system tumors, accounting for 30% of p...
Malignant glioblastoma multiforme, or glioma, is one of the most frequent central nervous system tum...
Objective: To evaluate characteristics and treatment responses of patients with high grade gliomas (...